Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

IBRXIBRX
Showing 7 of 9 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in IMMUNITYBIO INC

TWO SIGMA INVESTMENTS, LP holds 11.1M shares of IBRX (IMMUNITYBIO INC), worth $97.2M as of 2026-Q2. The position was increased (+153.0% shares). IBRX represents 0.1% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$97.2M

Current Shares

11.1M

Total Value Change

+$97.1M

Total Shares Change

+11.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
11.1M
+153.0%
$97.2M0.1%$8.76
48
2026-Q1
Decreased
4.4M
-7.0%
$33.6M0.0%$10.00
0
2025-Q4
Increased
4.7M
+80.9%
$9.3M0.0%$1.98
42
2025-Q3
Increased
2.6M
+224.9%
$6.4M0.0%$2.57
44
2025-Q2
Increased
802,563
+3272.1%
$2.1M0.0%$2.70
42
2025-Q1
Decreased
23,800
-15.9%
$71,6380.0%$3.14
0
2024-Q4
New
28,317
-
$72,4920.0%$2.68
29

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used